NCT00062738View on ClinicalTrials.gov

Treatment of Depression in Parkinson's Disease Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

52

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Parkinson DiseaseDepression

Interventions

DRUG

paroxetine

Paroxetine CR 12.5 - 25 mg q hs

DRUG

Nortriptyline

nortriptyline 25 - 75 mg q hs

OTHER

placebo

matching placebo

Trial Locations (1)

08901

Robert Wood Johnson Medical School, New Brunswick

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Rutgers, The State University of New Jersey

OTHER

NCT00062738 - Treatment of Depression in Parkinson's Disease Trial | Biotech Hunter | Biotech Hunter